Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2011. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares, executed under authority granted by shareholders at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 980,000 ordinary shares of 25 pence each.
- Purchase Date: July 4, 2011.
- Price Range: Highest price paid was 1,348.5 pence per share; lowest price paid was 1,336.5 pence per share.
- Treasury Holdings (Settled): 469,174,284 shares (8.38% of total issued share capital).
- Treasury Holdings (Including Unsettled): 472,304,284 shares (9.20% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,132,731,215 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 980,000 shares on July 4, 2011. Consequently, the percentage of shares held in Treasury increased to 8.38% of total issued share capital, and the percentage of total voting rights held in Treasury (including unsettled shares) reached 9.20%.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. The stated intention for the purchased shares is to hold them in Treasury. The document notes that the number of shares in issue (excluding treasury shares) represents the total voting rights and serves as the denominator for shareholder notification calculations under the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (469,174,284 settled) against the company's latest capitalization table.
- Confirm the total issued share capital to validate the 8.38% treasury holding percentage.
- Check the status of unsettled shares to confirm the 9.20% voting rights figure.
- Review the remaining authorization for share buybacks following this transaction.